Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Palliative Care in Metastatic Pancreatic Cancer

July 25th 2018

Metastatic Pancreatic Cancer: Treatment Approaches

July 25th 2018

Role of Chemoradiation in Resectable Pancreatic Cancer

July 25th 2018

Adjuvant Therapy in Locally Advanced Pancreatic Cancer

July 25th 2018

Locally Advanced Pancreas Cancer: Phase II LAPACT Trial

July 25th 2018

Adjuvant/Neoadjuvant Therapy for Pancreatic Cancer

July 25th 2018

Molecular Testing in Pancreatic Adenocarcinoma

July 25th 2018

Precision Oncology in Advanced Pancreatic Cancer

July 25th 2018

The Rising Incidence of Early-Onset CRC: What Do We Know and What Can We Do?

July 24th 2018

During an OncLive Peer Exchange® program on individualizing treatment and improving outcomes for patients with CRC, a panel of experts shared their insights on early-onset CRC, which has been observed to occur as early as adolescence.

Dr. Eng Discusses Results of the PRODIGE 7 Trial

July 23rd 2018

Cathy Eng, MD, professor of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center, discusses why the negative results of the PRODIGE 7 trial are beneficial moving forward.

Dr. Bekaii-Saab on Adjuvant Therapy in Pancreatic Cancer

July 21st 2018

Tanios Bekaii-Saab, MD, medical oncologist, Mayo Clinic, discusses adjuvant therapy in pancreatic cancer.

Dr. Agarwala on Impact of Combining Entinostat with Pembrolizumab

July 20th 2018

Sanjiv S. Agarwala, MD, chief of medical oncology and hematology, St. Luke’s Cancer Center, professor of medicine, Temple University School of Medicine, discusses the impact of combining entinostat with pembrolizumab (Keytruda) across a number of tumor types.

Dr. Ulahannan on the VALENTINO Trial in Advanced CRC

July 20th 2018

Susanna Ulahannan, MD, assistant professor, Section of Hematology/Oncology, associate director, Oklahoma TSET Phase I Program, Stephenson Cancer Center, The University of Oklahoma, discusses the VALENTINO trial in advanced colorectal cancer (CRC).

Progress in Pancreatic Cancer: ASCO Studies Move the Needle

July 19th 2018

New strategies for the use of standard chemotherapies are likely to improve outcomes for a significant subset of patients with pancreatic cancer.

Dr. Shah Highlights Immunotherapy for Esophageal Cancer

July 19th 2018

Manish A. Shah, MD, director of gastrointestinal oncology and chief of Solid Tumor Service at Weill Cornell Medicine/NewYork-Presbyterian Hospital, highlights immunotherapy for esophageal cancer.

FDA Grants Atezolizumab Combo Breakthrough Designation for Frontline HCC

July 18th 2018

The FDA has granted atezolizumab a breakthrough therapy designation for use in combination with bevacizumab as a first-line treatment for patients with advanced or metastatic hepatocellular carcinoma.

Evolving Global Treatment Landscape for Gastric Cancer

July 18th 2018

Novel Targeted Approaches in Gastroesophageal Cancer

July 18th 2018

Checkpoint Inhibitors: Emerging Role in GE Cancer

July 18th 2018

Shortfalls in Recent Gastroesophageal Clinical Trials

July 18th 2018